Literature DB >> 6347896

Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines.

A A Lindberg, J A Robertsson.   

Abstract

Groups of six calves, 4 to 5 weeks old, were vaccinated either orally with a live auxotrophic Salmonella typhimurium (O-antigen 1,4,12) SL1479 vaccine (10(8) bacteria on day zero, 10(10) bacteria on days 7 and 14) or subcutaneously with a heat-inactivated (56 degrees C, 30 min) S. typhimurium SVA1232 vaccine (10(10) bacteria suspended in 30% [vol/vol] aluminum hydroxide on days zero, 7, and 14). The calves were then orally challenged with either 10(6) (approximately 100 X the 25% lethal dose) or 10(9) (approximately 100,000 X the 25% lethal dose) live bacteria of the calf-virulent S. typhimurium SVA44 strain. The immune reactivity of these calves and of nonvaccinated control calves was followed before and after the challenge infection up to 42 days by (i) intradermal injection of S. typhimurium crude extract, outer membrane protein preparation (porins), and lipopolysaccharide (LPS), (ii) in vitro stimulation of peripheral blood lymphocytes estimated by using uptake of [3H]thymidine, with S. typhimurium crude extract, porins, LPS, and polysaccharide (O-antigenic polysaccharide chain free of lipid A), and Salmonella sp. serotype thompson (O-antigen 6,7) strain IS40 LPS and polysaccharide, and (iii) estimation of the class-specific immunoglobulin G (IgG) and IgM antibody responses against S. typhimurium LPS and porins, and Salmonella sp. serotype thompson LPS. The immune studies showed that in calves given the live vaccine orally, the skin test reactivity and lymphocyte stimulation indices were significantly higher (P values ranging from less than 0.025 to less than 0.0005) against homologous, but not heterologous, antigens than those seen in calves given the heat-inactivated vaccine subcutaneously. In contrast, the IgG and IgM antibody titers against homologous LPS and porins were significantly higher (P less than 0.0005) in sera collected on day 21 from calves given the heat-inactivated vaccine than in calves given the live vaccine. After the oral challenge, calves given the live vaccine showed reduced cell-mediated immune reactions, in agreement with the observation that the host defense could eradicate the challenge organism, whereas calves given the heat-inactivated vaccine showed significantly increased cell-mediated immune reactions (P values ranging from less than 0.025 to less than 0.005), in agreement with the observation that in these calves, the challenge strain caused enteritis as well as systemic invasion. The increased cell-mediated immune reactivity in calves given the live vaccine correlated well with the excellent protection against challenge infection seen in these animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347896      PMCID: PMC264705          DOI: 10.1128/iai.41.2.751-757.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Immunity in experimental salmonellosis. 3. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium.

Authors:  R Germanier
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

Review 2.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

Review 3.  Resistance to intracellular infection.

Authors:  G B Mackaness
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

Review 4.  Typhoid fever: pathogenesis and immunologic control. 2.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

5.  Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.

Authors:  R H Gilman; R B Hornick; W E Woodard; H L DuPont; M J Snyder; M M Levine; J P Libonati
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

6.  The immunization of mice and calves with gal E mutants of Salmonella typhimurium.

Authors:  C Wray; W J Sojka; J A Morris; W J Brinley Morgan
Journal:  J Hyg (Lond)       Date:  1977-08

7.  The protection of calves against infection with Salmonella typhimurium by means of a vaccine prepared from Salmonella dublin (strain 51).

Authors:  J D Rankin; R J Taylor; G Newman
Journal:  Vet Rec       Date:  1967-06-24       Impact factor: 2.695

8.  Comparative immunogenicity of heat-killed and living oral Salmonella vaccines.

Authors:  F M Collins; P B Carter
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

9.  Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations.

Authors:  G F Ames; E N Spudich; H Nikaido
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.

Authors:  N F Pierce
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Vaccination against Salmonella Infection: the Mucosal Way.

Authors:  Rémi Gayet; Gilles Bioley; Nicolas Rochereau; Stéphane Paul; Blaise Corthésy
Journal:  Microbiol Mol Biol Rev       Date:  2017-06-14       Impact factor: 11.056

2.  Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs.

Authors:  M J Kennedy; R J Yancey; M S Sanchez; R A Rzepkowski; S M Kelly; R Curtiss
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Animal Models for Salmonellosis: Applications in Vaccine Research.

Authors:  Ellen E Higginson; Raphael Simon; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

4.  Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate.

Authors:  G L Cooper; L M Venables; M J Woodward; C E Hormaeche
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  A clinical field trial to evaluate the efficacy of vaccination in controlling Salmonella infection and the association of Salmonella-shedding and weight gain in pigs.

Authors:  Abdolvahab Farzan; Robert M Friendship
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

6.  Immune response of pigs to parenteral vaccination with an aromatic-dependent mutant of Salmonella typhimurium.

Authors:  J S Lumsden; B N Wilkie
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

7.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

Authors:  M M Levine; D Herrington; J R Murphy; J G Morris; G Losonsky; B Tall; A A Lindberg; S Svenson; S Baqar; M F Edwards
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

8.  Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines.

Authors:  J A Robertsson; A A Lindberg; S Hoiseth; B A Stocker
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

9.  Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.

Authors:  Ellen E Higginson; Girish Ramachandran; Aruna Panda; Steven T Shipley; Edwin H Kriel; Louis J DeTolla; Michael Lipsky; Darren J Perkins; Rosangela Salerno-Goncalves; Marcelo B Sztein; Marcela F Pasetti; Myron M Levine; Sharon M Tennant
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

10.  Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells.

Authors:  A Aggarwal; S Kumar; R Jaffe; D Hone; M Gross; J Sadoff
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.